BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schmitt M, Greten FR. The inflammatory pathogenesis of colorectal cancer. Nat Rev Immunol 2021. [PMID: 33911231 DOI: 10.1038/s41577-021-00534-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Li W, Wu Z, Meng W, Zhang C, Cheng M, Chen Y, Zou Y, Li K, Lin S, Xiong W, Wang Y, Lin Y, Ma W, Zhou W. Blockade of IL-6 inhibits tumor immune evasion and improves anti–PD-1 immunotherapy. Cytokine 2022;158:155976. [DOI: 10.1016/j.cyto.2022.155976] [Reference Citation Analysis]
2 Zhou B, Yu J, Cai X, Wu S. Constructing a molecular subtype model of colon cancer using machine learning. Front Pharmacol 2022;13:1008207. [DOI: 10.3389/fphar.2022.1008207] [Reference Citation Analysis]
3 Chen X, Cao M, Wang P, Chu S, Li M, Hou P, Zheng J, Li Z, Bai J. The emerging roles of TRIM21 in coordinating cancer metabolism, immunity and cancer treatment. Front Immunol 2022;13:968755. [DOI: 10.3389/fimmu.2022.968755] [Reference Citation Analysis]
4 Knauss A, Gabel M, Neurath MF, Weigmann B. The Memory T Cell “Communication Web” in Context with Gastrointestinal Disorders—How Memory T Cells Affect Their Surroundings and How They Are Influenced by It. Cells 2022;11:2780. [DOI: 10.3390/cells11182780] [Reference Citation Analysis]
5 Yücel Ç, Karatoprak GŞ, Açıkara ÖB, Akkol EK, Barak TH, Sobarzo-sánchez E, Aschner M, Shirooie S. Immunomodulatory and anti-inflammatory therapeutic potential of gingerols and their nanoformulations. Front Pharmacol 2022;13:902551. [DOI: 10.3389/fphar.2022.902551] [Reference Citation Analysis]
6 Făgărășan V, Andraș D, Amarinei G, Seicean RI, Bințințan VV, Dindelegan GC, Căinap CI. Absolute and Functional Iron Deficiency in Colon Cancer: A Cohort Study. Medicina 2022;58:1202. [DOI: 10.3390/medicina58091202] [Reference Citation Analysis]
7 Wang Y, Zhang Z, Sun W, Zhang J, Xu Q, Zhou X, Mao L. Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets. Biomedicine & Pharmacotherapy 2022;153:113524. [DOI: 10.1016/j.biopha.2022.113524] [Reference Citation Analysis]
8 Li X, Yang Y, Zhang B, Lin X, Fu X, An Y, Zou Y, Wang JX, Wang Z, Yu T. Lactate metabolism in human health and disease. Signal Transduct Target Ther 2022;7:305. [PMID: 36050306 DOI: 10.1038/s41392-022-01151-3] [Reference Citation Analysis]
9 Loktionov A. Colon mucus in colorectal neoplasia and beyond. World J Gastroenterol 2022; 28(32): 4475-4492 [DOI: 10.3748/wjg.v28.i32.4475] [Reference Citation Analysis]
10 Shao B, Chai N, Yao Y, Li J, Law HKW, Linghu E. Autophagy in gastrointestinal cancers. Front Oncol 2022;12:975758. [DOI: 10.3389/fonc.2022.975758] [Reference Citation Analysis]
11 Ahsan H, Islam SU, Ahmed MB, Lee YS. Role of Nrf2, STAT3, and Src as Molecular Targets for Cancer Chemoprevention. Pharmaceutics 2022;14:1775. [DOI: 10.3390/pharmaceutics14091775] [Reference Citation Analysis]
12 Mahmod AI, Haif SK, Kamal A, Al-Ataby IA, Talib WH. Chemoprevention effect of the Mediterranean diet on colorectal cancer: Current studies and future prospects. Front Nutr 2022;9:924192. [PMID: 35990343 DOI: 10.3389/fnut.2022.924192] [Reference Citation Analysis]
13 Lu L, Dong J, Liu Y, Qian Y, Zhang G, Zhou W, Zhao A, Ji G, Xu H. New insights into natural products that target the gut microbiota: Effects on the prevention and treatment of colorectal cancer. Front Pharmacol 2022;13:964793. [DOI: 10.3389/fphar.2022.964793] [Reference Citation Analysis]
14 Li W, Sun Y, Chen J, Jiang Z, Yang J, Wang F. PEGylated Cisplatin Nanoparticles for Treating Colorectal Cancer in a pH-Responsive Manner. Journal of Immunology Research 2022;2022:1-11. [DOI: 10.1155/2022/8023915] [Reference Citation Analysis]
15 Kim N, Gim JA, Lee BJ, Choi BI, Yoon HS, Kim SH, Joo MK, Park JJ, Kim C. Crosstalk between mucosal microbiota, host gene expression, and sociomedical factors in the progression of colorectal cancer. Sci Rep 2022;12:13447. [PMID: 35927305 DOI: 10.1038/s41598-022-17823-7] [Reference Citation Analysis]
16 Caspi A, Entezari AA, Crutcher M, Snook AE, Waldman SA. Guanylyl cyclase C as a diagnostic and therapeutic target in colorectal cancer. Per Med 2022. [PMID: 35920071 DOI: 10.2217/pme-2022-0026] [Reference Citation Analysis]
17 Sher G, Masoodi T, Patil K, Akhtar S, Kuttikrishnan S, Ahmad A, Uddin S. Dysregulated FOXM1 Signaling in the regulation of cancer stem cells. Semin Cancer Biol 2022:S1044-579X(22)00180-8. [PMID: 35931301 DOI: 10.1016/j.semcancer.2022.07.009] [Reference Citation Analysis]
18 Abu-Hanna J, Patel JA, Anastasakis E, Cohen R, Clapp LH, Loizidou M, Eddama MMR. Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature. Clin Epigenetics 2022;14:98. [PMID: 35915507 DOI: 10.1186/s13148-022-01305-8] [Reference Citation Analysis]
19 Younis NK, Roumieh R, Bassil EP, Ghoubaira JA, Kobeissy F, Eid AH. Nanoparticles: attractive tools to treat colorectal cancer. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.08.006] [Reference Citation Analysis]
20 Li Y, Qiu Z, Wang Q, Li S, Zhang Q, Han J, Yi M. Identification of a Novel Tumor Inflammation Signature for Risk Stratification, Prognosis Prediction, and Immune Status in Colorectal Cancer. BioMed Research International 2022;2022:1-17. [DOI: 10.1155/2022/3465391] [Reference Citation Analysis]
21 Qiao H, Tan XR, Li H, Li JY, Chen XZ, Li YQ, Li WF, Tang LL, Zhou GQ, Zhang Y, Liang YL, He QM, Zhao Y, Huang SY, Gong S, Li Q, Ye ML, Chen KL, Sun Y, Ma J, Liu N. Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China. JAMA Oncol 2022. [PMID: 35834269 DOI: 10.1001/jamaoncol.2022.2810] [Reference Citation Analysis]
22 Colombo F, Illescas O, Noci S, Minnai F, Pintarelli G, Pettinicchio A, Vannelli A, Sorrentino L, Battaglia L, Cosimelli M, Dragani TA, Gariboldi M. Gut microbiota composition in colorectal cancer patients is genetically regulated. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-15230-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Martínez-Montoro JI, Martínez-Sánchez MA, Balaguer-Román A, Gil-Martínez J, Mesa-López MJ, Egea-Valenzuela J, Ruiz-Alcaraz AJ, Queipo-Ortuño MI, Ferrer M, Fernández-García JC, Ramos-Molina B. Dietary modulation of gut microbiota in patients with colorectal cancer undergoing surgery: A review. Int J Surg 2022;104:106751. [PMID: 35803517 DOI: 10.1016/j.ijsu.2022.106751] [Reference Citation Analysis]
24 Hall DCN, Benndorf RA. Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited. Cell Mol Life Sci 2022;79:393. [PMID: 35780223 DOI: 10.1007/s00018-022-04430-y] [Reference Citation Analysis]
25 Lorentz A, Bilotta S, Civelek M. Molecular links between allergy and cancer. Trends in Molecular Medicine 2022. [DOI: 10.1016/j.molmed.2022.06.003] [Reference Citation Analysis]
26 Rampado R, Biccari A, D'Angelo E, Collino F, Cricrì G, Caliceti P, Giordano F, Taraballi F, Pucciarelli S, Agostini M. Optimization of Biomimetic, Leukocyte-Mimicking Nanovesicles for Drug Delivery Against Colorectal Cancer Using a Design of Experiment Approach. Front Bioeng Biotechnol 2022;10:883034. [PMID: 35757799 DOI: 10.3389/fbioe.2022.883034] [Reference Citation Analysis]
27 Wang J, Liu B, Cao J, Zhao L, Wang G. MIR31HG Expression Predicts Poor Prognosis and Promotes Colorectal Cancer Progression. Cancer Manag Res 2022;14:1973-86. [PMID: 35733512 DOI: 10.2147/CMAR.S351928] [Reference Citation Analysis]
28 Li J, Zhu Y, Yang L, Wang Z. Effect of gut microbiota in the colorectal cancer and potential target therapy. Discov Oncol 2022;13:51. [PMID: 35749000 DOI: 10.1007/s12672-022-00517-x] [Reference Citation Analysis]
29 Liu C, Liu D, Wang F, Xie J, Liu Y, Wang H, Rong J, Xie J, Wang J, Zeng R, Xie Y. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma. Front Oncol 2022;12:876660. [DOI: 10.3389/fonc.2022.876660] [Reference Citation Analysis]
30 Xiao C, Chi Q, Wang X. Recent Progress in Mass Spectrometry-based Metabolomics for Colorectal Cancer. Chem Res Chin Univ . [DOI: 10.1007/s40242-022-2119-5] [Reference Citation Analysis]
31 Yan H, Li Y, Wang X, Qian J, Xu M, Peng J, Huang D. The Alteration of T-Cell Heterogeneity and PD-L1 Colocalization During dMMR Colorectal Cancer Progression Defined by Multiplex Immunohistochemistry. Front Oncol 2022;12:867658. [DOI: 10.3389/fonc.2022.867658] [Reference Citation Analysis]
32 Hu X, Chen Z, Wang Z, Xiao Q. Cancer evolution: special focus on the immune aspect of cancer. Semin Cancer Biol 2022:S1044-579X(22)00117-1. [PMID: 35589072 DOI: 10.1016/j.semcancer.2022.05.006] [Reference Citation Analysis]
33 Kasprzak A. Role of the Ghrelin System in Colorectal Cancer. Int J Mol Sci 2022;23:5380. [PMID: 35628187 DOI: 10.3390/ijms23105380] [Reference Citation Analysis]
34 Pączek S, Łukaszewicz-Zając M, Mroczko B. Granzymes-Their Role in Colorectal Cancer. Int J Mol Sci 2022;23:5277. [PMID: 35563668 DOI: 10.3390/ijms23095277] [Reference Citation Analysis]
35 Cheng KJ, Mohamed EHM, Syafruddin SE, Ibrahim ZA. Interleukin-1 alpha and high mobility group box-1 secretion in polyinosinic:polycytidylic-induced colorectal cancer cells occur via RIPK1-dependent mechanism and participate in tumourigenesis. J Cell Commun Signal 2022. [PMID: 35534784 DOI: 10.1007/s12079-022-00681-3] [Reference Citation Analysis]
36 Sena P, Mancini S, Pedroni M, Reggiani Bonetti L, Carnevale G, Roncucci L. Expression of Autophagic and Inflammatory Markers in Normal Mucosa of Individuals with Colorectal Adenomas: A Cross Sectional Study among Italian Outpatients Undergoing Colonoscopy. Int J Mol Sci 2022;23:5211. [PMID: 35563601 DOI: 10.3390/ijms23095211] [Reference Citation Analysis]
37 Wang Z, Zhang Z, Zhang K, Zhou Q, Chen S, Zheng H, Wang G, Cai S, Wang F, Li S. Multi-Omics Characterization of a Glycerolipid Metabolism-Related Gene Enrichment Score in Colon Cancer. Front Oncol 2022;12:881953. [DOI: 10.3389/fonc.2022.881953] [Reference Citation Analysis]
38 Palumbo JS. Crosstalk between hemostasis and immunity in cancer pathogenesis. Thrombosis Research 2022;213:S3-7. [DOI: 10.1016/j.thromres.2021.12.013] [Reference Citation Analysis]
39 Mukherji R, Weinberg BA, Pedersen KS. Immunotherapy for Colorectal Cancer. Hematology/Oncology Clinics of North America 2022. [DOI: 10.1016/j.hoc.2022.02.010] [Reference Citation Analysis]
40 Hussain A. Therapeutic applications of engineered chimeric antigen receptors-T cell for cancer therapy. Beni-Suef Univ J Basic Appl Sci 2022;11. [DOI: 10.1186/s43088-022-00238-8] [Reference Citation Analysis]
41 Zhang X, Hong R, Bei L, Yang J, Zhao X, Hu Z, Chen L, Meng H, Zhang Q, Niu G, Yue Y, Ke C. Selenium binding protein 1 inhibits tumor angiogenesis in colorectal cancers by blocking the Delta-like ligand 4/Notch1 signaling pathway. Translational Oncology 2022;18:101365. [DOI: 10.1016/j.tranon.2022.101365] [Reference Citation Analysis]
42 Dong A, Lin C, Echeveste CE, Huang Y, Oshima K, Yearsley M, Chen X, Yu J, Wang L. Protocatechuic Acid, a Gut Bacterial Metabolite of Black Raspberries, Inhibits Adenoma Development and Alters Gut Microbiome Profiles in ApcMin/+ Mice. J Cancer Prev 2022;27:50-7. [DOI: 10.15430/jcp.2022.27.1.50] [Reference Citation Analysis]
43 Qiao Z, Wang X, Wang C, Han J, Qi W, Zhang H, Liu Z, You C. Lactobacillus paracasei BD5115-Derived 2-Hydroxy-3-Methylbutyric Acid Promotes Intestinal Epithelial Cells Proliferation by Upregulating the MYC Signaling Pathway. Front Nutr 2022;9:799053. [DOI: 10.3389/fnut.2022.799053] [Reference Citation Analysis]
44 Cai J, Sun L, Gonzalez FJ. Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis. Cell Host Microbe 2022;30:289-300. [PMID: 35271802 DOI: 10.1016/j.chom.2022.02.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 13.0] [Reference Citation Analysis]
45 Jia S, Han Y, Yang R, Yang Z. Chemokines in Colon Cancer Progression. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.02.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
46 Tevini J, Eder SK, Huber-schönauer U, Niederseer D, Strebinger G, Gostner JM, Aigner E, Datz C, Felder TK. Changing Metabolic Patterns along the Colorectal Adenoma–Carcinoma Sequence. JCM 2022;11:721. [DOI: 10.3390/jcm11030721] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
47 Oliveira LFS, Predes D, Borges HL, Abreu JG. Therapeutic Potential of Naturally Occurring Small Molecules to Target the Wnt/β-Catenin Signaling Pathway in Colorectal Cancer. Cancers 2022;14:403. [DOI: 10.3390/cancers14020403] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
48 Qiu C, Shi W, Wu H, Zou S, Li J, Wang D, Liu G, Song Z, Xu X, Hu J, Geng H. Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma. Front Immunol 2021;12:769685. [PMID: 35003085 DOI: 10.3389/fimmu.2021.769685] [Reference Citation Analysis]
49 Wei J, Bu Z, Ji J. A commentary on : “A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells” – tumor microenvironment: the Achilles heel of cancer. Medical Review 2021;1:126-8. [DOI: 10.1515/mr-2021-0032] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Degirmenci B, Dincer C, Demirel HC, Berkova L, Moor AE, Kahraman A, Hausmann G, Aguet M, Tuncbag N, Valenta T, Basler K. Epithelial Wnt secretion drives the progression of inflammation-induced colon carcinoma in murine model. iScience 2021;24:103369. [PMID: 34849464 DOI: 10.1016/j.isci.2021.103369] [Reference Citation Analysis]
51 Barresi V. Colorectal Cancer: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines 2021;9:1858. [PMID: 34944674 DOI: 10.3390/biomedicines9121858] [Reference Citation Analysis]
52 Lucafò M, Curci D, Franzin M, Decorti G, Stocco G. Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention. Front Pharmacol 2021;12:772101. [PMID: 34744751 DOI: 10.3389/fphar.2021.772101] [Reference Citation Analysis]
53 Zhang W, An Y, Qin X, Wu X, Wang X, Hou H, Song X, Liu T, Wang B, Huang X, Cao H. Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges. Front Oncol 2021;11:739648. [PMID: 34733783 DOI: 10.3389/fonc.2021.739648] [Reference Citation Analysis]
54 Popov J, Caputi V, Nandeesha N, Rodriguez DA, Pai N. Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies. Int J Mol Sci 2021;22:11365. [PMID: 34768795 DOI: 10.3390/ijms222111365] [Reference Citation Analysis]
55 Welz L, Kakavand N, Hang X, Laue G, Ito G, Silva MG, Plattner C, Mishra N, Tengen F, Ogris C, Jesinghaus M, Wottawa F, Arnold P, Kaikkonen L, Stengel S, Tran F, Das S, Kaser A, Trajanoski Z, Blumberg R, Roecken C, Saur D, Tschurtschenthaler M, Schreiber S, Rosenstiel P, Aden K. Epithelial X-Box Binding Protein 1 Coordinates Tumor Protein p53-Driven DNA Damage Responses and Suppression of Intestinal Carcinogenesis. Gastroenterology 2021:S0016-5085(21)03606-4. [PMID: 34599932 DOI: 10.1053/j.gastro.2021.09.057] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
56 Ku MS, Liu CY, Hsu CY, Chiu HM, Chen HH, Chan CC. Association of Ambient Fine Particulate Matter (PM2.5) with Elevated Fecal Hemoglobin Concentration and Colorectal Carcinogenesis: A Population-Based Retrospective Cohort Study. Cancer Control 2021;28:10732748211041232. [PMID: 34525876 DOI: 10.1177/10732748211041232] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Wang S, Liu Y, Li J, Zhao L, Yan W, Lin B, Guo X, Wei Y. Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality. Front Cell Dev Biol 2021;9:710165. [PMID: 34490259 DOI: 10.3389/fcell.2021.710165] [Reference Citation Analysis]
58 Bracci L, Fabbri A, Del Cornò M, Conti L. Dietary Polyphenols: Promising Adjuvants for Colorectal Cancer Therapies. Cancers (Basel) 2021;13:4499. [PMID: 34572726 DOI: 10.3390/cancers13184499] [Reference Citation Analysis]
59 Liu Y, Li X, Yang Y, Liu Y, Wang S, Ji B, Wei Y. Exploring Gut Microbiota in Patients with Colorectal Disease Based on 16S rRNA Gene Amplicon and Shallow Metagenomic Sequencing. Front Mol Biosci 2021;8:703638. [PMID: 34307461 DOI: 10.3389/fmolb.2021.703638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Pereira JFS, Jordan P, Matos P. A Signaling View into the Inflammatory Tumor Microenvironment. Immuno 2021;1:91-118. [DOI: 10.3390/immuno1020007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]